AI-based prediction of actionable genomic alterations from H&E-stained slides
Precision oncology based on the identification of actionable genomic alterations (AGAs) has been transformative in the care of solid tumors, yet optimal treatment selection is often hindered by tissue exhaustion and slow turnaround times. Artificial intelligence (AI) addresses these barriers by predicting AGAs directly from routine hematoxylin and eosin (H&E)-stained slides. Recent landmark studies, including the prospective EAGLE and ANNAR trials, have demonstrated that deep learning models can identify alterations such as EGFR in non-small cell lung cancer and FGFR in urothelial cancer across diverse global cohorts. By providing near-instant, non-destructive results, AI-based prediction can triage patients for molecular testing or clinical trials at the time of initial diagnosis. This perspective evaluates the maturing evidence base and outlines a pragmatic pathway for integrating these tools into clinical practice. Ultimately, these models offer the opportunity to extract critical molecular information from slides generated in every laboratory worldwide and to significantly improve timely access to the rapidly evolving therapeutic landscape of solid tumors.
Authors
- Woochan Hwang (ORCID: https://orcid.org/0000-0002-9874-7772)
- Kashif Alam Firozvi
- Vivek Subbiah (ORCID: https://orcid.org/0000-0002-6064-6837)
- Fernando López‐Ríos (ORCID: https://orcid.org/0000-0001-6813-0395)
- Siraj Mahamed Ali (ORCID: https://orcid.org/0000-0001-7477-4023)
Institutions
- Universidad Complutense de Madrid (ES)
- Mount Auburn Hospital (US)
- Research Institute Hospital 12 de Octubre (ES)
- Maryland Oncology Hematology (US)
- Hospital Universitario 12 De Octubre (ES)
- Stanford Medicine (US)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- Lunit (South Korea) (KR)
- Stanford University (US)
Publication Details
- Journal
- npj Precision Oncology
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1038/s41698-026-01772-9
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00